PYRAZOLOPYRIMIDINVERBINDUNGEN

European patent · EP3068786 · In force

Register entry

Publication number
EP3068786
Application number
EP14861448
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 14, 2014
Published
Sep 21, 2016
Granted
Jun 6, 2018
Protection ends at the latest
Nov 13, 2034
Next annual fee due
Nov 30, 2026
IPC classes
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/CA2013/000957 15.11.2013
PCT application
PCT/CA2014/051091 14.11.2014
PCT publication
WO2015/070349 21.05.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 29, 2026

    Change

    Published in Swissreg on 29.05.2026

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Jul 28, 2018

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 28.07.2018

  6. Jun 6, 2018

    Granted

    Published in Swissreg on 06.06.2018

Parties

Holder

University Health Network

190 Elizabeth Street R. Fraser Elliott Building - Room 1S-417, Toronto, Ontario M5G 2C4, CA

Agent

Ing. Marco Zardi c/o M. ZARDI & Co. S.A.

via Pioda 6, 6900 Lugano

Inventor

LAUFER, Radoslaw

Oakville, Ontario L6M 4C8, CA

NG, Grace

Markham, Ontario L6C 0K8, CA

LI, Sze-Wan

Toronto, Ontario M5N 1K2, CA

PAULS, Heinz W.

Oakville, Ontario L6L 5A4, CA

LIU, Yong

Oakville, Ontario L6H 3K5, CA

PATEL, Narendra Kumar B.

Brampton, Ontario L6R 2R4, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.